Patrick J. McEnany - 06 Dec 2022 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role: President and CEO, Director
Signature: /s/ Patrick J. McEnany
Issuer symbol: CPRX
Transactions as of: 06 Dec 2022
Net transactions value: $0
Form type: 4
Filing time: 08 Dec 2022, 16:03:28 UTC
Previous filing: 22 Nov 2022
Next filing: 29 Dec 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CPRX	Common Stock, par value $0.001 per share	Options Exercise		+30,834	+0.79%		3,933,440	06 Dec 2022	Direct	F1
transaction	CPRX	Common Stock, par value $0.001 per share	Tax liability		-12,133	-0.31%		3,921,307	06 Dec 2022	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CPRX	Restricted Stock Units	Options Exercise	$0	-30,834	-1.1%	$0.000000	2,835,000	06 Dec 2022	Common Stock	30,834		Direct	F1, F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.
F2	Shares withheld by the Registrant to satisfy applicable withholding taxes upon vesting of restricted stock units.
F3	Derivative securities vested in equal tranches, 1/3rd on December 2, 2020, 1/3rd on December 2, 2021 and 1/3rd on December 2, 2022.
F4	Shares of common stock are required to be delivered to the Reporting Person within sixty days of vesting. The final tranche of shares was delivered on December 6, 2022.